ArticleAmerican journal of hematology2025

Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.

Christian Récher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.